Additionally, BRAFV600E was shown to induce expression of factors such as IL-10 and IL-1α, which can induce tolerogenic forms of dendritic cells and cancer-associated fibroblasts (CAFs), respectively [40]. The gene discussed is IL1A; the disease is cancer.